- Home
- CGTX vs CHMI Comparison
CGTX vs CHMI Comparison
Compare CGTX & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CGTX | CHMI |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.5M | 93.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CGTX | CHMI |
|---|---|---|
| Price | $0.88 | $2.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $3.33 | $3.00 |
| AVG Volume (30 Days) | ★ 1.4M | 237.9K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 14.98% |
| EPS Growth | ★ 62.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $61.13 |
| P/E Ratio | ★ N/A | $139.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $2.17 |
| 52 Week High | $3.83 | $3.14 |
Technical Indicators
Market Signals| Indicator | CGTX | CHMI |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | 52.44 |
| Support Level | $0.55 | $2.49 |
| Resistance Level | $1.19 | $2.74 |
| Average True Range (ATR) | 0.13 | 0.09 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 52.41 | 63.75 |
Price Performance
Historical ComparisonAbout CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.